[HTML][HTML] Nutritional aspects in inflammatory bowel diseases
P Balestrieri, M Ribolsi, MPL Guarino, S Emerenziani… - Nutrients, 2020 - mdpi.com
Crohn's disease (CD) and ulcerative colitis (UC) are chronic, relapsing, inflammatory
disorders of the digestive tract that characteristically develop in adolescence and early …
disorders of the digestive tract that characteristically develop in adolescence and early …
malnutrition/sarcopenia and frailty in patients with cirrhosis
C Bunchorntavakul, KR Reddy - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background Malnutrition/sarcopenia and frailty are common in patients with cirrhosis and
are associated with poor outcomes. Aim To provide an overview of data on the importance …
are associated with poor outcomes. Aim To provide an overview of data on the importance …
[HTML][HTML] Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis
X Tantai, Y Liu, YH Yeo, M Praktiknjo, E Mauro… - Journal of …, 2022 - Elsevier
Background & Aims The association between sarcopenia and prognosis in patients with
cirrhosis remains to be determined. In this study, we aimed to quantify the association …
cirrhosis remains to be determined. In this study, we aimed to quantify the association …
Sarcopenia in patients with cirrhosis after transjugular intrahepatic portosystemic shunt placement
J Liu, J Ma, C Yang, M Chen, Q Shi, C Zhou, S Huang… - Radiology, 2022 - pubs.rsna.org
Background Sarcopenia is frequently found in patients with cirrhosis and is associated with
liver dysfunction, cirrhosis-related complications, and poorer quality of life. Purpose To …
liver dysfunction, cirrhosis-related complications, and poorer quality of life. Purpose To …
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China
X Zeng, ZW Shi, JJ Yu, LF Wang, YY Luo… - Journal of cachexia …, 2021 - Wiley Online Library
Background Diagnostic criteria for sarcopenia have not been established in Chinese. This
study established criteria based on the L3‐skeletal muscle index (L3‐SMI) and assessed its …
study established criteria based on the L3‐skeletal muscle index (L3‐SMI) and assessed its …
[HTML][HTML] An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic …
YJ Yang, DJ Kim - International journal of molecular sciences, 2021 - mdpi.com
The prevalence of osteoporosis and sarcopenia is significantly higher in patients with liver
disease than in those without liver disease and osteoporosis and sarcopenia negatively …
disease than in those without liver disease and osteoporosis and sarcopenia negatively …
[HTML][HTML] Sarcopenia: Ammonia metabolism and hepatic encephalopathy
A Jindal, RK Jagdish - Clinical and molecular hepatology, 2019 - ncbi.nlm.nih.gov
Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and
adversely affects the quality of life; cirrhosis related liver decompensation and significantly …
adversely affects the quality of life; cirrhosis related liver decompensation and significantly …
[HTML][HTML] Sarcopenia in chronic liver disease: a metabolic perspective
R Kumar, SS Prakash, RN Priyadarshi… - Journal of clinical and …, 2022 - ncbi.nlm.nih.gov
Sarcopenia, a condition of low muscle mass, quality, and strength, is commonly found in
patients with chronic liver disease (CLD) and is associated with adverse clinical outcomes …
patients with chronic liver disease (CLD) and is associated with adverse clinical outcomes …
Nutrition in chronic liver disease: consensus statement of the Indian national association for study of the liver
Malnutrition and sarcopenia are common in patients with chronic liver disease and are
associated with increased risk of decompensation, infections, wait-list mortality and poorer …
associated with increased risk of decompensation, infections, wait-list mortality and poorer …
[HTML][HTML] Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors
Background Sarcopenia has been underscored as a significant predictor of poor prognosis
in cancer patients undergoing immunotherapy with programmed death-1 (PD-1) inhibitors …
in cancer patients undergoing immunotherapy with programmed death-1 (PD-1) inhibitors …